UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
FDA OKs AbbVie’s Hepatitis C drug to shorten treatment duration
AbbVie said that the U.S. Food and Drug Administration (FDA) has approved M...
by Lee Han-soo
|
2019-10-08 18:04
라인
Allergan Korea to replace breast implant without time limit
Allergan Korea CEO Kim Ji-hyun said she would lift the two-year time limit ...
by Lee Hye-seon
|
2019-10-08 15:22
라인
Most of weight loss drug Saxenda irregularly distributed
Saxenda, a prescription medicine for weight loss, gained immense popularity...
by Kwak Sung-sun
|
2019-10-08 15:19
라인
Yuyang DNU, NSCI to develop treatment for dry macular degeneration
Yuyang DNU and Neural Stem Cell Institute (NSCI), a U.S. NGO research insti...
by Lee Han-soo
|
2019-10-07 16:54
라인
Sanofi confirms prolonged PFS in patients with advanced gastric cancer
Sanofi has published the results of a clinical trial PRODIGY, which evaluat...
by Lee Han-soo
|
2019-10-07 14:39
라인
Galderma Korea workers feel insecure after separation from Nestle
Galderma has debuted as a rebranded dermatology company after separation fr...
by Kim Yun-mi
|
2019-10-07 14:38
라인
Albis most prescribed ranitidine drug with carcinogen risk
Physicians have prescribed Albis Tab. the most among ranitidine-containing ...
by Kwak Sung-sun
|
2019-10-07 11:23
라인
Qurient sets up joint firm with Nobel chemistry prize winner
Qurient has established a joint venture with Professors Robert Huber, a res...
by Lee Han-soo
|
2019-10-04 17:45
라인
Lilly's Verzenio extends life for women with advanced breast cancer
Lilly said a combination therapy of Verzenio and fulvestrant significantly ...
by Lee Han-soo
|
2019-10-04 16:15
라인
Eisai’s hepatocellular carcinoma treatment Lenvima to get insurance benefit
The government said it would grant insurance benefit to Eisai’s Lenvima (in...
by Lee Han-soo
|
2019-10-02 16:10
라인
CDK4/6 inhibitor+fulvestrant combo nears getting benefit
The combination therapy of cyclin-dependent kinase 4/6 (CDK 4/6) inhibitor ...
by Kim Yun-mi
|
2019-10-02 16:03
라인
Daewoong's EU partner wins sales approval for BTX
Daewoong Pharmaceutical said that Evolus, its U.S. and EU partner, has rece...
by Lee Han-soo
|
2019-10-02 14:51
라인
Daewoong's reaffirms drug-marketing power with Daiichi Sankyo's NOAC treatment
Daewoong proved its sales power once again as it solidified its top positio...
by Lee Han-soo
|
2019-10-01 16:43
라인
Drugmakers’ illegal rebates down, support for doctors up
Pharmaceutical companies’ offering of illicit rebates to physicians have de...
by Kwak Sung-sun
|
2019-10-01 13:49
라인
Crystal Genomics confirms efficacy of epigenetics-based pulmonary fibrosis treatment
Crystal Genomics said it has presented the results of the preclinical study...
by Lee Han-soo
|
2019-10-01 11:21
라인
‘Merck Korea unilaterally lays off employees’
Merck Biopharma Korea has been embroiled in a labor dispute.Merck Korea bra...
by Kim Yun-mi
|
2019-10-01 11:09
라인
Allergan to compensate breast implant recipients for damage
Allergan agreed to provide full compensation for the medical expenses of pa...
by Lee Hye-seon
|
2019-09-30 15:33
라인
Ranitidine recall taking heavy toll on pharmaceuticals
Pharmaceutical companies are expected to suffer massive losses due to the r...
by Jeong Sae-im
|
2019-09-30 15:16
라인
Sale of Novartis’ conjunctivitis drug Pataday banned for 3 months
The Ministry of Food and Drug Safety has suspended the sale of Novartis Kor...
by Lee Hye-seon
|
2019-09-30 11:25
라인
Investor trust in bio-industrialists sank due to latter’s unethical acts
The biotech industry is losing trust from investors as some executives at t...
by Lee Han-soo
|
2019-09-27 15:11
-
이전
31
32
33
34
35
36
37
38
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top